- COVID-19 and Performing CPR in the Community
- COVID-19 – Message from NIPC Medical & Research Director
- Advice On The Coronavirus For Individuals Living With Heart Disease And Stroke
- UP TO 150,000 IRISH BLOOD PRESSURE PATIENTS MAY NOT NEED ADDITIONAL DRUG TREATMENT DESPITE NEW GUIDELINES
- NIPC Wins Gold at Top Healthcare Awards Ceremony!
Prof. J. William McEvoy – US National Library of Medicine National Institutes of Health
Cancer Survivorship and Subclinical Myocardial Damage.
Am J Epidemiol. 2019 12 31;188(12):2188-2195
Authors: Florido R, Lee AK, McEvoy JW, Hoogeveen RC, Koton S, Vitolins MZ, Shenoy C, Russell SD, Blumenthal RS, Ndumele CE, Ballantyne CM, Joshu CE, Platz EA, Selvin E
Abstract Cancer survivors might have an excess risk of cardiovascular disease (CVD) resulting from toxicities of cancer therapies and a high burden of CVD risk factors. We sought to uate the association of cancer survivorship with subclinical myocardial damage, as assessed by elevated high-sensitivity cardiac troponin T (hs-cTnT) test results. We included 3,512 participants of the Atherosclerosis Risk in Communities Study who attended visit 5 (2011-2013) and were free of CVD (coronary heart disease, heart failure, or stroke). We used multivariate logistic regression to uate the cross-sectional associations of survivorship from any, non-sex-related, and sex-related cancers (e.g., breast, prostate) with elevated hs-cTnT (≥14 ng/L). Of 3,512 participants (mean age, 76 years; 62% women; 21% black), 19% were cancer survivors. Cancer survivors had significantly higher odds of elevated hs-cTnT (OR = 1.26, 95% CI: 1.03, 1.53). Results were similar for survivors of non-sex-related and colorectal cancers, but there was no association between survivorship from breast and prostate cancers and elevated hs-cTnT. Results were similar after additional adjustments for CVD risk factors. Survivors of some cancers might be more likely to have elevated hs-cTnT than persons without prior cancer. The excess burden of subclinical myocardial damage in this population might not be fully explained by traditional CVD risk factors.
PMID: 30927355 [PubMed - indexed for MEDLINE]